Skip to main content

Table 3 Patient characteristics of smokers by Country, CV ASPIRE study, Europe, 2011

From: Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: Results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV-ASPIRE) Study

Characteristic Greece (N=571) Italy (N=443) Netherlands (N=425) Total (N=1439)
Mean age, years (age range) 55.6 (39–91) 58.2 (39–85) 59.2 (40–85) 57.4 (39–91)
Gender, n (%)     
Male 352 (61.5%) 263 (58.8%) 199 (46.7%) 814 (56.3%)
Female 220 (38.5%) 184 (41.2%) 227 (53.3%) 631 (43.7%)
Mean BMI, kg/m2 (range) 27.6 (12–54) 26.0 (17–43) 27.5 (16–54) 27.1 (12–54)
Primary reason for seeking medical advice, n (%)
General medical examination 319 (57.2%) 249 (27.1%) 64 (16.1%) 629 (45.3%)
Cardiovascular related 68 (12.2%) 31 (7.2%) 126 (31.7%) 225 (16.2%)
Psychiatric related 15 (2.7%) 14 (3.2%) 20 (5.0%) 49 (3.5%)
Pulmonary related 49 (8.8%) 21 (4.9%) 52 (13.1%) 122 (8.8%)
Gastrointestinal related 34 (6.1%) 34 (7.9%) 12 (3.0%) 80 (5.8%)
Metabolic related 46 (8.2%) 29 (6.7%) 37 (9.3%) 112 (8.1%)
Prescription 22 (3.9%) 6 (1.4%) 1 (0.3%) 29 (2.1%)
Other 12 (2.2%) 57 (13.2%) 89 (22.4%) 158 (11.4%)
Lipid levels     
Mean total cholesterol, mmol/L (SD) 5.7 (1.19) 5.4 (1.27) 5.2 (1.19) 5.5 (1.24)
Mean HDL cholesterol, mmol/L (SD) 1.3 (0.38) 1.3 (0.37) 1.3 (0.59) 1.3 (0.45)
Mean LDL cholesterol, mmol/L (SD) 3.7 (1.05) 3.3 (0.89) 3.2 (1.10) 3.4 (1.04)
Blood pressure     
Systolic blood pressure, mmHg (SD) 135.5 (18.65) 130.9 (14.59) 140.4 (17.42) 135.5 (17.50)
Diastolic blood pressure, mmHg (SD) 82.5 (9.70) 78.7 (8.24) 83.2 (10.63) 81.6 (9.75)
Medical history, n (%)     
Cardiovascular diseases 97 (17.0%) 69 (15.6%) 137 (32.2%) 303 (21.1%)
Diabetes 100 (17.5%) 74 (16.7%) 130 (30.6%) 304 (21.1%)
Hypertension 353 (61.8%) 192 (43.3%) 238 (56.0%) 783 (54.4%)
Hypercholesterolemia 372 (65.1%) 161 (36.3%) 193 (45.4%) 726 (50.5%)
Chronic obstructive pulmonary disease 81 (14.2%) 88 (19.9%) 114 (26.8%) 283 (19.7%)
Currently treated with medication (yes), n (%)
Diabetes 88 (15.4%) 65 (14.7%) 107 (25.2%) 260 (18.1%)
Hypertension 280 (49.0%) 184 (41.5%) 205 (48.2%) 669 (46.5%)
Hypercholesterolemia 240 (42.0%) 97 (21.9%) 153 (36.0%) 490 (34.1%)
Chronic obstructive pulmonary disease 48 (8.4%) 49 (11.1%) 86 (20.2%) 183 (12.7%)
Family medical history, n (%)     
Cardiovascular diseases 205 (35.9%) 100 (22.6%) 129 (30.4%) 434 (30.2%)
Diabetes 168 (29.4%) 77 (17.4%) 91 (21.4%) 336 (23.3%)
Hypertension 280 (49.0%) 138 (31.2%) 107 (25.2%) 525 (36.5%)
Hypercholesterolemia 205 (35.9%) 76 (17.2%) 70 (16.5%) 351 (24.4%)
Chronic obstructive pulmonary disease 66 (11.6%) 23 (5.2%) 59 (13.9%) 148 (10.3%)
Number of medical conditions, n (%)     
No conditions 105 (18.4%) 145 (32.7%) 75 (17.6%) 325 (22.6%)
1 condition 136 (23.8%) 126 (28.4%) 107 (25.2) 369 (25.6%)
2 condition 181 (31.7%) 96 (21.7%) 100 (23.5%) 377 (26.2%)
3 condition 100 (17.5%) 43 (9.7%) 81 (19.1%) 224 (15.6%)
4 condition 40 (7.0%) 28 (6.3%) 48 (11.3%) 116 (8.1%)
5 condition 9 (1.6%) 5 (1.1%) 14 (3.3%) 28 (1.9%)
Other disorder characteristics, n (%)     
Persistent chronic cough 214 (37.6%) 138 (31.7%) 121 (28.5%) 473 (33.1%)
Excess mucous and phlegm 115 (20.3%) 64 (14.7%) 101 (23.8%) 280 (19.6%)
Shortness of breath 217 (38.2%) 104 (23.9%) 106 (25.0%) 427 (29.9%)
Wheezing 95 (16.8%) 45 (10.3%) 67 (15.8%) 207 (14.5%)